Skip to main content




Difficulties resulting from China's zero-Covid policy being compounded by ineffectiveness of Sinovac jab against Omicron. Underlines the growing challenges China faces and the resultant impact on manufacturing, shipping and more as well as the human cost. on.ft.com/3xHklSe

3925546